Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹248.80
5.80 (2.39%)
High VOLATILITY
As on 12 Jun 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹2.30K Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
N/A
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹162.19+53.4%
52W High₹349.8-28.9%
Current Price
₹248.80
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹199.04
Upper Circuit₹298.56
Reference Price
₹248.80
Investment Checklist
Head and Shoulders on 1D (BREAKOUT CONFIRMED) — target ₹197.8
Double Top on 1D (BREAKOUT CONFIRMED) — target ₹282.2
3-day momentum: +20.9% — strong upward pressure
Trend: Price above all key MAs — strong uptrend
Unusual volume detected (4.5x average) — institutional activity likely
Technical Analysis
Technical Analysis
Analysis from 2026-06-12
Confidence
40%
Trend
BULLISH
BULLISH
Price above all key MAs — strong uptrend
EMA20
214.96
EMA50
211.37
EMA200
236.37
Price Action
MIXED
NEUTRAL
Higher Highs5
Higher Lows5
Lower Highs4
Lower Lows4
Support & Resistance Levels
Resistance (Above)
₹250.10
₹254.00
₹257.35
₹260.00
₹270.00
Support (Below)
₹235.80
₹227.85
₹221.00
₹214.19
₹205.36
Volume Analysis
TrendINCREASING
Change+625.40%
Unusual Volume
Yes (4.52x avg)
Recent MA Crossovers
20/50 Bearish Cross
4 days ago
SELL
10/20 Bullish Cross
2 days ago
BUY
Stop Loss Levels
Fixed Risk
1% Risk₹246.31
3% Risk₹241.34
5% Risk₹236.36
7% Risk (Custom)
₹231.38Technical Levels
1x ATR (Volatility)₹236.23
2x ATR (Swing)₹223.66
3x ATR (Trend)₹211.09
Immediate Support₹235.80
Moving Averages
EMA 9 (Short-term)₹220.49
EMA 20 (Medium-term)₹214.96
EMA 50 (Trend)₹211.37
EMA 200 (Long-term)₹236.37
Financials
Financial Analysis
| Metric | Mar '25 | Jun '25 | Sep '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹383.9 Cr | ₹429.1 Cr | ₹471.8 Cr | ₹434.3 Cr |
| Net Profit | ₹-40.4 Cr | ₹-35.8 Cr | ₹-7.9 Cr | ₹-29.8 Cr |
| EPS | — | ₹-3.94 | ₹-1.00 | ₹-3.20 |
| Operating Profit | ₹-3 Cr | ₹19.2 Cr | ₹43.3 Cr | ₹26.3 Cr |
ROE
-7.21%
ROCE
-0.61%
Debt/Equity
0.97
Current Ratio
1.24
OPM
6.06%
NPM
-6.86%
Peer Comparison
PharmaceuticalsPeer Comparison
| Symbol | Name | Price | Change |
|---|---|---|---|
| SUNPHARMA | Sun Pharmaceutical Industries Limited | ₹1,807.70 | +0.75% |
| DIVISLAB | Divi's Laboratories Limited | ₹6,638.00 | -0.26% |
| TORNTPHARM | Torrent Pharmaceuticals Limited | ₹4,571.20 | -0.02% |
| CIPLA | Cipla Limited | ₹1,389.40 | +0.44% |
| ZYDUSLIFE | Zydus Lifesciences Limited | ₹1,104.70 | -0.11% |
| DRREDDY | Dr. Reddy's Laboratories Limited | ₹1,275.40 | -0.05% |
| LUPIN | Lupin Limited | ₹2,293.30 | +0.88% |
| MANKIND | Mankind Pharma Limited | ₹2,381.10 | +0.35% |
| AUROPHARMA | Aurobindo Pharma Limited | ₹1,472.80 | +0.59% |
| LAURUSLABS | Laurus Labs Limited | ₹1,394.30 | +0.25% |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 04 Sept 2025 | Dividend - Re 0.20 Per Share | DIVIDEND |
| 19 Sept 2024 | Annual General Meeting/Dividend - Rs 1.50 Per Share | AGM |
| 18 Sept 2023 | Annual General Meeting/Dividend - Rs 2.25 Per Share | AGM |
| 14 Sept 2022 | Annual General Meeting/Dividend - Rs 1.50 Per Share/Special Dividend- Rs 0.75 Per Share | AGM |
| 17 Sept 2021 | Annual General Meeting/Dividend - Rs 1.50 Per Share | AGM |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for INDOCO
View AllNEWS
neutral
Business Standard - Markets 2d ago
PPAP Automotive Ltd leads gainers in 'B' group
Unichem Laboratories Ltd, Indoco Remedies Ltd, AVG Logistics Ltd and Motisons Jewellers Ltd are among the other gainers in the BSE's 'B' group today, 11 June 2026.
AVGAVG-REBSEINDOCOMOTISONSPPAPSJLOGISTICUNICHEMLABAutomobile and Auto ComponentsConsumer Durables
NEWS
positive
Business Standard - Markets 15d ago
Indoco Remedies climbs after Baddi plant secures EU GMP certification; ICICI Prudential MF buys 1.47% stake
Indoco Remedies rose 4.04% to Rs 211.60 after the company said its oral solid dosage formulations facility at Baddi, Himachal Pradesh, received European Union Good Manufacturing Practice (EU GMP) certification from the German Health Authority (Berlin
ALPL30IETFAUTOIETFBANKIETFBSE500IETFCASHIETFCOMMOIETFCONSUMIETFEVIETFFINIETFFMCGIETFGOLDIETFGSEC10IETFGSEC5IETFHEALTHIETFICICIAMCICICIB22ICICIPRULIINDOCOINFRAIETFITIETFLIQUIDIETFLOWVOLIETFMEDANTAMETALIETFMIDCAPIETFMIDSELIETFMOM30IETFNEXT50IETFNIF100IETFNIFTYIETFNV20IETFOILIETFPSUBNKIETFPVTBANIETFQUAL30IETFSENSEXIETFSILVERIETFTOP15IETFVAL30IETFFinancial ServicesFINANCIAL SERVICES
positive
CNBC TV18 - Markets 15d ago
Indoco Remedies gets EU GMP certification for Himachal Pradesh's Baddi OSD facility
On Wednesday (May 27), shares of Indoco Remedies Ltd ended at ₹202.90, up by ₹9.05, or 4.67%, on the BSE.
BSEINDOCOFinancial ServicesHealthcare